Tata Chemicals shares in focus after Q4 hit by impairment, weak soda ash realisations
Tata Chemicals reported an 85.3% year-on-year plunge in Q4FY24 net profit to ₹145.7 crore, with revenue declining 21.1% to ₹3,475 crore, primarily due to an impairment charge of ₹963 crore in its UK operations and weaker soda ash realisations. The company's EBITDA fell 58.7% YoY, and net debt increased to ₹8,506 crore. Despite the challenging results, the board recommended a dividend of ₹15 per share.
May 05 2026 07:05:00
Tata Chemicals Ltd - 500770 - Audio Recording Of Analysts/Investors Call Pertaining To The Financial Results For The Quarter And Financial Year Ended March 31, 2026
Tata Chemicals announced the availability of the audio recording for its Analysts/Investors Call, which discussed the Q4 FY26 and full financial year results. The call took place on May 4, 2026, the same day the board approved the results.
May 04 2026 21:05:00
Tata Chemicals Limited
Tata Chemicals Limited's Board has recommended a final dividend of Rs. 11 per equity share for the financial year ending March 31, 2026. This dividend is subject to approval from shareholders at the upcoming Annual General Meeting, with the record date to be announced subsequently.
May 04 2026 19:05:00
Tata Chemicals swings to massive ₹2,132 crore loss in Q4, profits shrink despite steady sales
Tata Chemicals reported a consolidated net loss of ₹2,132 crore for Q4 FY26, significantly wider than ₹156 crore in the year-ago period, primarily due to exceptional charges of ₹1,837 crore for goodwill impairment in the US and ₹159 crore for deferred tax asset write-off. Revenue from operations marginally decreased by 2% YoY to ₹3,438 crore. Despite the loss, the board recommended a dividend of ₹11 per share for the financial year 2025-26.
May 04 2026 19:05:00
Tata Chemicals Ltd - 500770 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Tata Chemicals reported Q4 FY26 consolidated revenue of Rs.3,438 crore (down 2% YoY) and a net loss of Rs.279 crore before exceptional items. Results were significantly impacted by a Rs.1,837 crore exceptional charge for goodwill impairment in the US.
May 04 2026 18:05:00
Tata Chemicals Ltd - 500770 - Intimation Under Regulations 30 And 51 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''''SEBI Listing Regulations'''')
Tata Chemicals approved a Rs. 100 crore capital expenditure to debottleneck its salt manufacturing capacity at the Mithapur plant. This investment aims to add 82,500 TPA (tonnes per annum) of Iodised Vacuum Salt Dried (IVSD) capacity over the next 12 months to meet growing demand.
May 04 2026 18:05:00
Tata Chemicals Ltd - 500770 - Corporate Action-Board approves Dividend
Tata Chemicals' board recommended a final dividend of ₹11 per share for FY26, representing 110% of face value. This dividend is contingent on shareholder approval at the 87th Annual General Meeting.
May 04 2026 18:05:00
Tata Chemicals Ltd - 500770 - Board Meeting Outcome for Board Meeting Outcome - May 4, 2026
Tata Chemicals board approved Q4 FY26 consolidated net loss of ₹2,116 cr and full-year net loss of ₹1,715 cr. This includes a ₹1,837 cr goodwill impairment charge related to US operations. A final dividend of ₹11 per share for FY26 was recommended.
May 04 2026 17:05:00
Tata Chemicals Limited
Tata Chemicals informed about its listed debt securities for FY26. CARE Ratings Limited and CRISIL Ratings Limited have reaffirmed/assigned AA+ Stable credit ratings for its Non-Convertible Debentures (NCDs), indicating a very high degree of safety.
Apr 30 2026 20:04:00
Tata Chemicals Limited
Tata Chemicals board will meet on May 4, 2026, to approve the audited standalone and consolidated financial results for Q4 FY26 and the full fiscal year. They will also consider a final dividend for shareholders.
Apr 22 2026 17:04:00
Read More